Kemal Karaagac/LinkedIn
Oct 7, 2026, 02:41
Kemal Karaagac: Optimising DOAC Resumption After Major Bleeding in Atrial Fibrillation
Kemal Karaagac, Cardiologist at Cihangir Hospital, shared a post on X about a recent article by Nour Al-Hussainy et al, published in BMJ Journals, adding:
“Early DOAC resumption after major bleeding in AF may stroke risk but recurrent bleeding.
DOAC monotherapy offers strong stroke protection, despite higher bleeding risk.
Individualised decisions and further trials are needed to define the optimal timing for restarting DOACs.”
Title: Timing of anticoagulation restart after serious bleeding in atrial fibrillation
Authors: Nour Al-Hussainy, Kristian Kragholm, Søren Lundbye-Christensen, Christian Torp-Pedersen, Manan Pareek, Susette Krohn Therkelsen, Sam Riahi
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support